-
Wedbush Reaffirms Neutral Rating for Sage Therapeutics (NASDAQ:SAGE)
来源: Buzz FX / 13 2月 2025 10:11:11 America/Chicago
Wedbush Reaffirms Neutral Rating for Sage Therapeutics (NASDAQ:SAGE) Written by MarketBeat February 13, 2025 Share Link copied to clipboard. Sage Therapeutics ( NASDAQ:SAGE - Get Free Report ) 's stock had its "neutral" rating reaffirmed by
Read more...